Evaluation of free oxygen radicals and effect of Unani treatment in cases of anxiety

Review and validation of Ihtiraq in cases of anxiety disorders - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057254

Enrollment

Registered

2023-09-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

Intervention1: Ood Saleeb: Ood Saleeb 4gm twice daily Intervention2: Ood Saleeb: 4 gm twice daily for 6 weeks Control Intervention1: Placebo: Wheat flour 4 gm twice daily for 6 weeks

Eligibility

Inclusion criteria

Inclusion criteria: Patient having mild and moderate anxiety 14 to 24 on the basis of Hamilton Anxiety Rating Scale Patients between 18 to 60 years Both sexes

Exclusion criteria

Exclusion criteria: Pateints suffering from severe or unstable medical condition Patients suffering from major psychiatric disorders like psychosis and schizophrenia Pregnant and lactating women Patient who failed to give consent Patients of severe anxiety with panic disorder and other anxiety disorders

Design outcomes

Primary

Measure	Time frame
Hamilton Anxiety Rating Scale for assessment of anxiety Serum MDA concentration for oxidative stressTimepoint: Baseline and 6 weeks	—

Secondary

Measure	Time frame
Mean platelet volume & platelet count platelet distribution width red cell distribution widthTimepoint: Assessment before & after treatment	—

Countries

India

Contacts

Public ContactDr Mohammed Yasir

Ajmal Khan Tibbiya College

yasirm7@gmail.com9271579831

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026